PubMed (MeSH Keyword) for id: 71481097

Year	Number of Results
2013	2
2014	8
2015	15
2016	24
2017	19
2018	19
2019	22
2020	45
2021	63
2022	42
2023	46
2024	14

1

XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53-p21 and p27 pathways.

Chakravarti N, Boles A, Burzinski R, Sindaco P, Isabelle C, McConnell K, Mishra A, Porcu P. Chakravarti N, et al. Sci Rep. 2024 Apr 23;14(1):9305. doi: 10.1038/s41598-024-59994-5. Sci Rep. 2024. PMID: 38653804 Free PMC article.

2

Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin.

Mittal K, Cooper GW, Lee BP, Su Y, Skinner KT, Shim J, Jonus HC, Kim WJ, Doshi M, Almanza D, Kynnap BD, Christie AL, Yang X, Cowley GS, Leeper BA, Morton CL, Dwivedi B, Lawrence T, Rupji M, Keskula P, Meyer S, Clinton CM, Bhasin M, Crompton BD, Tseng YY, Boehm JS, Ligon KL, Root DE, Murphy AJ, Weinstock DM, Gokhale PC, Spangle JM, Rivera MN, Mullen EA, Stegmaier K, Goldsmith KC, Hahn WC, Hong AL. Mittal K, et al. Commun Biol. 2024 Apr 8;7(1):426. doi: 10.1038/s42003-024-06140-6. Commun Biol. 2024. PMID: 38589567 Free PMC article.

3

Selinexor targets expression of metabolic genes in Merkel cell carcinoma cells.

Moore SA, Landes JR, Simonette RA, He Q, Doan HQ, Rady PL, Tyring SK. Moore SA, et al. Arch Dermatol Res. 2024 Mar 23;316(4):111. doi: 10.1007/s00403-024-02848-x. Arch Dermatol Res. 2024. PMID: 38520531 No abstract available.

4

Selinexor in multiple myeloma.

Martino EA, Vigna E, Bruzzese A, Labanca C, Mendicino F, Lucia E, Olivito V, Zimbo A, Torricelli F, Neri A, Morabito F, Gentile M. Martino EA, et al. Expert Opin Pharmacother. 2024 Mar;25(4):421-434. doi: 10.1080/14656566.2024.2333376. Epub 2024 Mar 25. Expert Opin Pharmacother. 2024. PMID: 38503547 Review.

5

Selinexor for the treatment of patients with relapsed or refractory multiple myeloma.

Babar A, Babar M, Zubair H, Shahid A, Rafique S, Bano M, Waleed MS, Khan M, Inayat A, Safi D. Babar A, et al. J Oncol Pharm Pract. 2024 Apr;30(3):535-546. doi: 10.1177/10781552241235902. Epub 2024 Mar 8. J Oncol Pharm Pract. 2024. PMID: 38454813 Review.

6

The XPO1 inhibitor selinexor ameliorates bleomycin-induced pulmonary fibrosis in mice via GBP5/NLRP3 inflammasome signaling.

Zhang J, Zhang Y, Chen Q, Qi Y, Zhang X. Zhang J, et al. Int Immunopharmacol. 2024 Mar 30;130:111734. doi: 10.1016/j.intimp.2024.111734. Epub 2024 Feb 28. Int Immunopharmacol. 2024. PMID: 38422768 Free article.

7

The development and validation of a liquid chromatography tandem mass spectrometry method for the quantification of selinexor and its application in Chinese multiple myeloma patients.

Yan X, He X, Yang X, Zhao Q, Lou Y. Yan X, et al. Anal Methods. 2024 Feb 15;16(7):1050-1057. doi: 10.1039/d3ay02166a. Anal Methods. 2024. PMID: 38269419

8

Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor.

Gordan LN, Ray D, Ijioma SC, Dranitsaris G, Warner A, Heritage T, Fink M, Wenk D, Chadwick P, Khrystolubova N, Peles S. Gordan LN, et al. Curr Oncol. 2024 Jan 14;31(1):501-510. doi: 10.3390/curroncol31010034. Curr Oncol. 2024. PMID: 38248119 Free PMC article.

9

[Efficacy analysis of selinexor combined with hypomethylating agent in the treatment of refractory/relapsed acute myeloid leukemia exposed to venetoclax].

Zhang J, Song BQ, Kong X, Liu Y, Yang HL, Zong LH, Kong JY, Xu Y, Qiu HY, Wu DP. Zhang J, et al. Zhonghua Xue Ye Xue Za Zhi. 2023 Nov 14;44(11):936-939. doi: 10.3760/cma.j.issn.0253-2727.2023.11.009. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 38185524 Free PMC article. Chinese. No abstract available.

10

Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.

Uddin MH, Al-Hallak MN, Khan HY, Aboukameel A, Li Y, Bannoura SF, Dyson G, Kim S, Mzannar Y, Azar I, Odisho T, Mohamed A, Landesman Y, Kim S, Beydoun R, Mohammad RM, Philip PA, Shields AF, Azmi AS. Uddin MH, et al. Clin Transl Med. 2023 Dec;13(12):e1513. doi: 10.1002/ctm2.1513. Clin Transl Med. 2023. PMID: 38131168 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

275 results

Results by year